Lodz

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Asthma1 trial
• COPD1 trial
• Lupus (SLE)1 trial
• Multiple myeloma1 trial

Phase

• Phase 33 trials
• Phase 1/22 trials
• Phase 22 trials

Status

• Completed5 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• GlaxoSmithKline7 trials

Running trials

• Active, not recruiting

  Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

  NCT07084896· Phase 1/2· GlaxoSmithKline· Source

Closed trials

• Recruiting

  A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

  NCT07099898· Phase 3· GlaxoSmithKline· Source

• Completed

  A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

  NCT05496231· Phase 1/2· GlaxoSmithKline· Source

• Completed

  Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

  NCT04719832· Phase 3· GlaxoSmithKline· Source

• Completed

  Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

  NCT04133909· Phase 3· GlaxoSmithKline· Source

• Completed

  Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

  NCT03739710· Phase 2· GlaxoSmithKline· Source

• Completed

  Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

  NCT01649765· Phase 2· GlaxoSmithKline· Source